BrainHQ selected for NIH-funded Study for Long Covid Cognitive Issues
August 02, 2023 08:00 ET | Posit Science
SAN FRANCISCO, Aug. 02, 2023 (GLOBE NEWSWIRE) -- As announced by the US National Institutes of Health (NIH), BrainHQ is being incorporated into phase 2 clinical trials addressing persistent...
T.J. Geist, Allsup Principal Advocate
SSA’s New Guide: A Positive Step For Long COVID Sufferers, Allsup Ready To Assist With SSDI Claims
July 31, 2023 16:49 ET | Allsup
Belleville, Illinois, July 31, 2023 (GLOBE NEWSWIRE) -- The Social Security Administration (SSA) has issued new guidance for long COVID sufferers. The guide offers a clearer picture as to how this...
Intesa Sanpaolo presents Industrial Districts Report. Gros-Pietro, excellent rebound from Covid
July 19, 2023 05:19 ET | Intesa Sanpaolo
MILAN, Italy, July 19, 2023 (GLOBE NEWSWIRE) -- Focus on the rebound of businesses after the pandemic in Intesa Sanpaolo's "Economy and Finance of Industrial Districts 2022" Report, now in its 15th...
johnson fistel.jpg
Danaher (DHR) Faces Shareholder Class Action Lawsuit: Johnson Fistel Encourages Investors with Losses Exceeding $100,000 to Seek Representation
July 18, 2023 12:10 ET | Johnson Fistel, LLP
SAN DIEGO, July 18, 2023 (GLOBE NEWSWIRE) -- Johnson Fistel, LLP, a shareholder rights law firm, announces that a class action lawsuit has been filed on behalf of Danaher Corporation ("Danaher" or...
Sirona Biochem Advances Antiviral Research with New Compound Candidates for Testing at the ICGEB
June 28, 2023 09:00 ET | Sirona Biochem Corp.
VANCOUVER, British Columbia, June 28, 2023 (GLOBE NEWSWIRE) -- June 28, 2023 – Sirona Biochem Corp. (TSX-V: SBM) (FSE: ZSB) (OTC: SRBCF) ("Sirona") is excited to announce the development of a...
InflaRx on large white.jpg
InflaRx Appoints Dr. Camilla Chong as Chief Medical Officer
June 28, 2023 07:30 ET | InflaRx N.V.
Camilla Chong, M.D., joins the team with 25 years of experience in the global pharmaceutical industry in drug developmentDr. Chong to lead clinical development of InflaRx’s portfolio of C5a/C5aR...
InflaRx on large white.jpg
InflaRx Announces Commercial Launch of Gohibic (vilobelimab) in the U.S. for the Treatment of Critically Ill COVID-19 Patients
June 21, 2023 07:00 ET | InflaRx N.V.
Gohibic is now commercially available for hospitals in the U.S.Gohibic can be used under an Emergency Use Authorization (EUA) granted by the FDA for treatment of certain critically ill COVID-19...
Hospitals Improperly Refuse to Allow Ivermectin for COVID and Yet Defend Right to Do So, according to Journal of American Physicians and Surgeons
June 19, 2023 14:07 ET | Association of American Physicians and Surgeons
TUCSON, Ariz., June 19, 2023 (GLOBE NEWSWIRE) -- A number of hospitals have been sued for refusing to allow patients dying of COVID to receive treatment with ivermectin. If the hospital lost, it...
THE WALT DISNEY COMPANY INVESTOR ALERT: Kaplan Fox & Kilsheimer LLP Notifies Disney Investors of a Class Action Lawsuit and Upcoming Deadline
May 24, 2023 13:01 ET | Kaplan Fox & Kilsheimer LLP
NEW YORK, May 24, 2023 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP reminds investors that a complaint has been filed on behalf of purchasers of The Walt Disney Company (“Disney” or the...
HOK Signals its Investment in Downtown Los Angeles with Studio Relocation to the Arts District
April 27, 2023 11:00 ET | HOK
LOS ANGELES, April 27, 2023 (GLOBE NEWSWIRE) -- In a move that reflects its bold, creative and forward-thinking culture, HOK’s Los Angeles studio has chosen to relocate its award-winning Southern...